解读中等和 (非常) 高风险的非肌肉侵入性膀癌的分子异质性,使用多层-omics研究
Murat Akand1,2, Tatjana Jatsenko3,4, Tim Muilwijk1,2
1Department of Urology, University Hospitals Leuven, Leuven, Belgium.
Frontiers in oncology
|November 5, 2024
概括
这项研究使用多omics方法来了解膀癌异质性. 其目标是改善风险分层和个性化治疗非肌肉侵入性膀癌 (NMIBC) 患者.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 膀癌 (BC) 是一种常见的尿路恶性瘤,非肌肉侵入性BC (NMIBC) 占75%的病例.
- NMIBC的复发率高 (70%) 和进展率高 (15%),目前欧洲泌尿病学协会 (EAU) 的风险组显示出显著的结果异质性.
- 由于分子异质性,现有的模型在区分NMIBC患者的结果和预测治疗反应方面缺乏精度.
研究的目的:
- 解读中等和 (非常) 高风险NMIBC的分子异质性.
- 开发一个更准确的评分系统,以改善患者分层和治疗选择.
- 为了提高个性化治疗干预措施的复发和进展的预测.
主要方法:
- 采用多层次的 -omics 方法,包括基因组学,表观遗传学,转录组学,蛋白质组学,脂组学和代谢组学.
- 使用免疫组织病理学方法进行全面的瘤表征.
- 分析分子和病理性质,以确定预测和预后标记.
主要成果:
- 该研究假设,采用多组学方法将揭示NMIBC风险组内的分子区别.
- 这种组合策略预计将提供NMIBC表型的多维特征.
- 该方法旨在确定新的生物标志物,以改善风险分层和治疗反应预测.
结论:
- 一种组合的多omics方法有潜力准确预测NMIBC复发和进展.
- 这一策略可以导致开发基于分子特征的算法,以实现个性化的患者管理.
- 改进的分层将指导治疗干预,优化NMIBC患者的随访方案和治疗选择.
关键词:
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -膀癌:膀癌是一种癌症.表观遗传学是指表观遗传学.基因组学就是基因组学.不具有肌肉侵入性的方法.这是一个渐进的过程.复发性 复发性 复发性翻译学 翻译学 翻译学 翻译学
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...